SCHEMBL7156609

SCHEMBL7156609

COc1ccc(-c2nc(-c3ccc(C(F)(F)F)cn3)no2)c(O)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.47
SMN1; SMN2 Q16637 8/20 0.46
MAPT P10636 5/20 0.46
NPC1 O15118 4/20 0.46
TP53 P04637 4/20 0.46
ALDH1A1 P00352 4/20 0.46
RAB9A P51151 4/20 0.46
TDO2 P48775 2/20 0.43
IDO1 P14902 1/20 0.43
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 4/20 0.42
GAA P10253 3/20 0.42
HPGD P15428 1/20 0.42
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CHUK O15111 1/20 0.39
TXNRD1 Q16881 1/20 0.39
NOX4 Q9NPH5 1/20 0.39
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7158427 0.81 CASP3 (0.49) CASP3SMN1; SMN2MAPTNPC1TP53
SCHEMBL6449089 0.81 CASP3 (0.49) CASP3SMN1; SMN2MAPTNPC1TP53
SCHEMBL6457424 0.78 CASP3 (0.48) CASP3SMN1; SMN2MAPTNPC1TP53
SCHEMBL7051693 0.75 CHUK (0.68) CASP3SMN1; SMN2MAPTNPC1TP53
SCHEMBL7153588 0.73 CASP3 (0.53) CASP3NPC1KDM4ENPSR1CHUK
SCHEMBL7048686 0.72 CASP3 (0.52) CASP3NPC1RAB9ANPSR1CHUK
SCHEMBL6448883 0.71 CASP3 (0.48) CASP3MAPTPKMCHUKTXNRD1
SCHEMBL7188138 0.71 CASP3 (0.40) CASP3SMN1; SMN2MAPTNPC1TP53
SCHEMBL6452503 0.70 SMN1; SMN2 (0.48) SMN1; SMN2MAPTNPC1TP53ALDH1A1
SCHEMBL6452318 0.70 NPC1 (0.64) CASP3SMN1; SMN2MAPTNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 WO disclosed